Drug Delivery Business

Vaxess rebrands to Terrestrial Bio, raises $50M for GLP-1 patch

Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.
EurekAlert!

Emory University and Micron Biomedical launch first-in-human clinical trial of next-generation rotavirus vaccine delivered via dissolvable microarray technology

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
Business Wire

Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
Benzinga.com

Needle-Free Vaccine Technology For Measles-Rubella: Bill & Melinda Gates Foundation Fund Mass Production

The Gates foundation funds a US-based life science company for needle-free vaccine technology. The method utilizes dissolvable microneedles on a patch-like device Get the Strategy to Trade Pre-Fed ...
technologynetworks

Affymetrix Participates in Study to Advance MicroArray Technology Towards Widespread Clinical Use

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...